FS
About
Fred is the President and CEO of VedaBio and a Venture Partner at OMX Ventures with extensive experience in the healthcare industry. He currently serves as an Independent Director on several company Boards and holds an Adjunct Professor position at the University of Toronto. Prior to joining VedaBio, Fred held numerous senior leadership roles at MeMed Diagnostics, Versant Ventures, Northern Biologics (sold), bioMérieux and T2 Biosystems (IPO). Fred received his PhD in Molecular and Medical Genetics from the University of Toronto, and his BS from McGill University.
Position in the VCSift Database
- • 266 investors hold the President and CEO role in VCSift. Frédéric Sweeney is one of them.
- • 829 investors are based in San Diego, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Diego, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Frédéric
Search Investors